Using both conventional and edited MRS, we unequivocally assessed the presence of high 2HG levels in a non-glial tumor, encouraging pathologist to perform high throughput molecular screenings that confirmed the presence of the IDH1 mutation and allowed to identify an additional GNAS mutation. The gene discussed is IDH1; the disease is glioma.